Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM.DL)
CAPS Rating:
The Company is an innovation-driven biopharmaceutical company focuses on discovering, developing and commercializing medicines to change the lives of patients with cancer and inflammatory diseases.
RSS Headlines
Fool UK